BUSINESS ACQUISITIONS (Tables)

12 Months Ended

Dec. 31, 2023

BUSINESS ACQUISITIONS

Schedule of management's purchase price allocation

Cash	$	456
Accounts receivable		2,944
Inventory		3,551
Other assets		519
Property, plant & equipment		11,189
Operating leases right-of-use assets, net		1,231
Goodwill		33,360
Tradename		4,600
Customer relationships		5,800
Accounts payable and accrued expenses		(2,777)
Other current liabilities		(944)
Lease liabilities		(1,259)
Auto loans		(387)
Deferred tax liability		(627)
Bridge loan		(4,250)
Fair value of net assets acquired	$	53,406

Schedule of discount rate and remaining lease terms

Weighted average remaining lease term in years	3.8
Weighted average discount rate	8.3	%

Schedule of purchase price allocated to intangible assets

			Weighted Average
	Fair Value		Amortization Period		Weighted Average
Definite-lived Intangible Assets	Assigned		(Years)		Discount Rate
Customer relationships	$	5,800		10		23.50%
Tradename	$	4,600		Indefinite		23.50%

RX Pharmatech Ltd

BUSINESS ACQUISITIONS

Schedule of quantitative information associated with fair value measurement

The following table provides quantitative information associated with the initial fair value measurement of the Company’s liabilities for contingent consideration as of January 19, 2023:

	Maximum Payout					Weighted Average
Contingency Type	(undiscounted)		Fair Value		Unobservable Inputs	or Range
Revenue-based payments	$	1,550	$	1,138	Discount rate	16	%
					Projected year(s) of payment	2024-2026